Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Effects of a Lateral Position With Hip Flexion and Femoral Internal Rotation During the Second Stage of Labor in Nulliparous Women Receiving Epidural Analgesia

This randomized clinical study evaluated the effects of a lateral position with hip flexion and femoral internal rotation during the second stage of labor in nulliparous women receiving epidural labor analgesia. Participants were assigned to either an observation group using the modified lateral position or a control group using the conventional lateral position. The study compared second-stage labor duration, additional obstetric interventions, maternal outcomes, perineal outcomes, and neonatal outcomes between the two groups.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

230

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Zhejiang
      • Wenzhou, Zhejiang, Kina, 325000
        • Nanpu Branch of The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Nulliparous women.
  • Age 22 to 34 years.
  • Singleton pregnancy.
  • Cephalic presentation confirmed by ultrasonography after 37 weeks of gestation.
  • Gestational age of 37 to 41 weeks.
  • Estimated fetal weight of 2,500 to 3,500 g.
  • No birth-canal abnormalities on vaginal examination.
  • Effective epidural labor analgesia during the first stage of labor.
  • Sufficient cognitive capacity to understand and cooperate with the study procedures.
  • Ability and willingness to provide written informed consent.

Exclusion Criteria:

  • Organic heart, liver, or kidney disease.
  • Prenatal indication for cesarean delivery.
  • Pubic symphysis separation.
  • Lower-limb disease or impaired mobility.
  • Precipitous labor.
  • Second stage of labor lasting less than 30 minutes.
  • Severe mental illness.
  • Fetal malformation.
  • Withdrawal from the study.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Modified Lateral Position Group
Participants in this group adopted a lateral position with hip flexion and femoral internal rotation during the second stage of labor under midwife assistance.
Participants adopted a modified lateral position during the second stage of labor. The position involved lateral positioning facing the side opposite to the fetal back, hip flexion, knee flexion, and 30°-40° femoral internal rotation with midwife assistance. The position was used during uterine contractions with guided bearing-down efforts and was alternated with a semi-recumbent position according to the study protocol.
Aktiv komparator: Conventional Lateral Position Group
Participants in this group adopted the conventional lateral position during the second stage of labor under routine intrapartum care and midwife
Participants adopted the conventional lateral position during the second stage of labor under routine intrapartum care and midwife assistance. During uterine contractions, participants performed bearing-down efforts in the lateral position, followed by intervals of rest and semi-recumbent positioning according to the study protocol.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Duration of the Second Stage of Labor
Tidsramme: From full cervical dilatation to delivery of the neonate
From full cervical dilatation to delivery of the neonate
Additional Obstetric Interventions During the Second Stage of Labor
Tidsramme: During the second stage of labor
Additional obstetric interventions during the second stage of labor, classified as none, forceps-assisted vaginal birth, cesarean delivery during the second stage, vaginal birth after manual fetal-head rotation, or vaginal birth with episiotomy as the principal intervention.
During the second stage of labor

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Duration of the First Stage of Labor
Tidsramme: From onset of regular uterine contractions to full cervical dilatation
Duration of the first stage of labor, measured in minutes.
From onset of regular uterine contractions to full cervical dilatation
Duration of the Third Stage of Labor
Tidsramme: From delivery of the neonate to delivery of the placenta
Duration of the third stage of labor, measured in minutes.
From delivery of the neonate to delivery of the placenta
Postpartum Blood Loss
Tidsramme: Within 2 hours after delivery
Postpartum blood loss, measured in milliliters.
Within 2 hours after delivery
Perineal Outcomes
Tidsramme: At delivery
Perineal outcomes classified as intact perineum, episiotomy, first-degree perineal laceration, or second-degree or higher perineal laceration.
At delivery

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. februar 2025

Primær færdiggørelse (Faktiske)

30. december 2025

Studieafslutning (Faktiske)

30. december 2025

Datoer for studieregistrering

Først indsendt

30. juli 2026

Først indsendt, der opfyldte QC-kriterier

30. juli 2026

Først opslået (Faktiske)

4. august 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

4. august 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

30. juli 2026

Sidst verificeret

1. juli 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • SAHoWMU-CR2024-07-118

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .